OPTImal Management of Antithrombotic Agents: OPTIMA-5
Clinical trial NCT04116931 · UNKNOWN
Trial details
- NCT number
- NCT04116931
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-22
- Primary completion
- 2021-05-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.